Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients”

2 trials

Showing 2 of 2 results

Early research (Phase 1)Active Not RecruitingNCT02869217
What this trial is testing

Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors

Who this might be right for
NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive PatientsSynovial SarcomaMelanoma+5 more
University Health Network, Toronto 22
Very early researchUnknownNCT05648994
What this trial is testing

TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors

Who this might be right for
Solid Tumors
Fujian Cancer Hospital 30

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation